The ACR Research and Education Foundation: Ensuring the Future of Rheumatology
Attracting more quality doctors to the rheumatology field, and keeping them, is significantly influenced by the availability of rheumatology training and research funding.
For the past 25 years, the REF has offered an extensive core awards and grants portfolio that exists to train and develop rheumatologists and rheumatology health professionals and nurture novel research ideas for the future.
The core awards are designed to select the best in each niche of rheumatology, foster their ideas, and prepare them for larger awards and grants from other institutions to sustain their long-term careers.
This formula has allowed the Foundation to grow into the premier private source of funding for rheumatology training and research in the U.S., funding more than $5 million annually through its core awards and grants program.
The ACR REF Industry Roundtable: A Dynamic Collaboration Investing in the Future of Rheumatology
The Industry Roundtable brings together the REF and pharmaceutical industry leaders in a dynamic partnership while serving as a powerful forum for dialogue between the industry and the REF. As a direct result of the exemplary support of the Industry Roundtable members, the REF continues to increase funding for research and training.
Participation in the Industry Roundtable is a direct investment toward helping to ensure that well-trained and qualified rheumatologists are entering the field, while also making advancements in patient care.
2011-2012 Industry Roundtable Members:
If you are interested in learning more about the Industry Roundtable, please contact , director of Corporate Relations at
Ongoing communication and dialogue is a key touchstone of the Industry Roundtable membership. IRT members receive access to the following communication vehicles on a regular basis:
Other articles and resources of interest to IRT members include:
